This medication is a potent, third-generation EGFR inhibitor containing osimertinib. Healthcare providers prescribe Tagrisso 80mg Tablet for treat non-small cell lung cancer (NSCLC) that has a particular genetic mutation (EGFR T790M) or for early-stage cancer after surgery. Visit Globans Pharma to know more about the medicine.
Treat non-small cell lung cancer with Tagrisso 80mg Tablet
$0.00
More Information
This Ad has been viewed 1 time.